| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5616006 | The Journal of Heart and Lung Transplantation | 2017 | 9 Pages |
Abstract
Lower risk patients managed on parenteral treprostinil may be candidates for transition to a more convenient, oral form of the drug.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Murali M. MD, Jeremy P. MD, Franz DO, MSc, Michael MD, Meredith PharmD, Nicole BS, Kevin PharmD, R. James MD, PhD,